
The P21 Program in Bukhara, Uzbekistan
Nikki Hafezi, MAS IP ETHZ led the P21 program in Bukhara, combining keratoconus screening with multidisciplinary pediatric assessments for 400 children.

Nikki Hafezi, MAS IP ETHZ led the P21 program in Bukhara, combining keratoconus screening with multidisciplinary pediatric assessments for 400 children.

Dr. Emilio Torres-Netto presented ELZA-PACE cross-linking at BRASCRS 2025, a customised, tissue-preserving keratoconus vision rehabilitation method with promising clinical outcomes.

Accurate corneal topography depends as much on correct interpretation as on advanced technology. A recent ophta overview revisits the fundamentals that guide reliable clinical decision-making.

CAIRS for keratoconus: Prof Hafezi and Dr. Torres-Netto are featured in Ocular Surgery News, in which CAIRS experts highlight its role in rehabilitating highly irregular corneas.

In March 2025, Tashkent became the focal point for ophthalmology innovation as it hosted the Second International Conference on Innovative Technologies in Ophthalmology.

ELZA’s CEO, Nikki Hafezi launches a keratoconus screening initiative for children with Down syndrome in Uzbekistan, beginning in Andijan.

ECO-CAIRS extends tissue-based keratoconus surgery by optimizing allogenic ring segments through extracorporeal cross-linking.

Who is the best eye doctor in Zurich? In Switzerland? In the world? While such questions are subjective, peer recognition provides meaningful insight. The Ophthalmologist’s Power List 2025 highlights the individuals who are currently shaping the future of eye care. Among them is Prof. Farhad Hafezi, MD, PhD, FARVO, recognized for […]

At EgSCRS, ELZA’s pyramid approach to keratoconus: ELZA-sub400, PACE, ECO-CAIRS, and AI-guided diagnostics was presented in detail.

As part of the 70th Anniversary celebration of the Andijan State Medical Institute (ASMI) in Uzbekistan, ELZA Institute CEO, Nikki Hafezi, MAS IP ETHZ, took part in a series of high-level academic and institutional events from April 28 to May 1, 2025.
Stay informed & get the newsletter
You have successfully joined our subscriber list.
Newsletter abonnieren & informiert bleiben
Sie haben sich erfolgreich in unsere Abonnentenliste eingetragen.
Bitte bestätigen Sie Ihr Abonnement, indem Sie auf den Link in der E-Mail klicken, die wir Ihnen gerade geschickt haben.